NVS

Novartis AG NYSE

Healthcare ·Drug Manufacturers - General ·CH · novartis.com

$145.50

Mkt Cap $277.6B

52w Low $104.93 61.9% of range 52w High $170.46

50d MA $153.79 200d MA $137.68

P/E (TTM) 20.2x

EV/EBITDA 12.7x

P/B 6.1x

Debt/Equity 0.8x

ROE —

P/FCF 15.1x

RSI (14) —

ATR (14) —

Beta 0.52

50d MA $153.79

200d MA $137.68

Avg Volume 2.3M

About

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metaboli…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 28, 2026	BMO	2.11	1.99	-5.7%	144.19	+0.0%	+0.9%	-0.9%	+2.5%	+1.7%	+0.3%	—
Feb 4, 2026	BMO	1.99	2.03	+2.0%	149.86	+2.6%	+2.0%	+2.7%	+4.4%	+4.8%	+5.6%	—
Oct 28, 2025	BMO	2.26	2.25	-0.4%	129.14	-2.8%	-4.4%	-5.7%	-5.1%	-4.1%	-4.1%	—
Jul 17, 2025	BMO	2.38	2.42	+1.7%	118.37	-2.3%	-3.3%	-3.5%	-3.6%	-1.3%	-0.3%	—
Apr 29, 2025	BMO	2.12	2.28	+7.5%	112.63	+0.7%	+0.7%	+0.8%	-1.2%	+1.5%	+0.4%	—
Jan 31, 2025	BMO	1.80	1.98	+10.0%	104.75	+1.4%	-0.0%	+0.7%	+0.7%	+4.8%	+2.1%	—
Oct 29, 2024	BMO	1.94	2.06	+6.2%	115.63	-3.3%	-4.4%	-4.9%	-6.3%	-5.4%	-4.4%	—
Jul 18, 2024	BMO	1.89	1.97	+4.2%	111.80	-3.6%	-4.1%	-5.1%	-2.7%	-3.7%	-2.2%	—
Apr 23, 2024	BMO	1.73	1.80	+4.0%	95.12	+3.8%	+2.3%	+3.4%	+4.1%	+2.4%	+2.1%	—
Jan 31, 2024	BMO	1.64	1.53	-6.7%	107.75	-2.0%	-4.0%	-2.2%	-3.7%	-4.0%	-3.7%	—
Oct 24, 2023	BMO	1.70	1.74	+2.4%	94.69	-0.2%	+0.2%	+0.8%	-0.4%	-2.6%	-1.0%	—
Jul 18, 2023	BMO	1.68	1.83	+8.9%	93.62	+2.9%	+4.6%	+4.3%	+6.3%	+6.1%	+5.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 26	Morgan Stanley	Maintains	Overweight → Overweight	—	$150.75	$149.67	-0.7%	-0.7%	-1.7%	-0.3%	+1.3%	+2.9%
Jan 6	Barclays	Upgrade	Underweight → Equal Weight	—	$137.91	$139.09	+0.9%	+3.2%	+3.0%	+2.6%	+2.6%	+2.8%
Dec 8	JP Morgan	Upgrade	Neutral → Overweight	—	$132.16	$132.83	+0.5%	-1.5%	-0.9%	-0.7%	+0.2%	+0.3%
Sep 12	Goldman Sachs	Downgrade	Neutral → Sell	—	$127.70	$123.86	-3.0%	-2.8%	-3.4%	-3.9%	-4.1%	-4.2%
Feb 13	UBS	Downgrade	Buy → Neutral	—	$107.00	$106.96	-0.0%	+0.7%	-1.5%	-0.4%	-0.1%	+0.3%
Nov 19	Erste Group	Downgrade	Buy → Hold	—	$103.04	$102.58	-0.4%	+0.2%	+0.0%	+0.8%	+1.2%	+0.5%
Oct 30	BMO Capital	Maintains	Market Perform → Market Perform	—	$110.53	$110.63	+0.1%	-0.6%	-1.9%	-1.1%	-0.0%	-1.0%
Sep 11	BofA Securities	Downgrade	Buy → Neutral	—	$116.99	$114.98	-1.7%	-1.5%	-1.1%	-1.1%	-0.0%	-1.1%
Sep 5	Goldman Sachs	Downgrade	Buy → Neutral	—	$119.38	$117.74	-1.4%	-2.4%	-2.3%	-1.9%	-2.0%	-3.4%
Sep 3	Jefferies	Downgrade	Buy → Hold	—	$120.89	$119.13	-1.5%	-2.0%	-1.2%	-3.6%	-3.5%	-3.1%
Jul 2	Jefferies	Maintains	Buy → Buy	—	$106.54	$106.32	-0.2%	-0.1%	+0.2%	+1.5%	+1.4%	+1.6%
Apr 24	BMO Capital	Maintains	Market Perform → Market Perform	—	$97.28	$98.50	+1.3%	+1.1%	+1.8%	+0.2%	-0.2%	-0.2%
Sep 25	Morgan Stanley	Upgrade	Underweight → Equal Weight	—	$95.71	$95.41	-0.3%	+0.7%	+0.3%	-0.9%	+1.2%	+0.7%
May 9	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$81.21	$80.06	-1.4%	-2.7%	-1.7%	-2.1%	-0.5%	+0.0%
Dec 6	Exane BNP Paribas	Downgrade	Outperform → Neutral	—	$75.70	$75.96	+0.3%	+0.7%	+0.9%	+1.7%	+0.6%	+0.8%
Dec 3	Bryan Garnier	Downgrade	Buy → Neutral	—	$75.65	$76.29	+0.8%	+0.1%	+0.7%	+0.9%	+1.8%	+0.6%
Sep 20	Deutsche Bank	Downgrade	Hold → Sell	—	$78.99	$77.65	-1.7%	-0.8%	-0.5%	-0.8%	+0.1%	-0.7%
Mar 10	Argus	Downgrade	Buy → Hold	—	$79.05	$79.97	+1.2%	+0.8%	+1.4%	+0.7%	+2.1%	+3.0%
Feb 1	Cowen & Co.	Downgrade	Outperform → Market Perform	—	$85.61	$85.85	+0.3%	-0.8%	-0.9%	-1.2%	+0.2%	+0.1%
Sep 1	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$81.44	$83.17	+2.1%	+0.9%	+3.3%	+1.2%	+0.7%	+1.5%
Feb 25	Guggenheim Securities	Downgrade	Buy → Neutral	—	$85.24	$85.70	+0.5%	-2.4%	-3.3%	-4.5%	-6.8%	-3.6%
Feb 25	Guggenheim	Downgrade	Buy → Neutral	—	$85.24	$85.70	+0.5%	-2.4%	-3.3%	-4.5%	-6.8%	-3.6%
Apr 25	Guggenheim	Upgrade	Neutral → Buy	—	$73.64	$75.23	+2.2%	+3.6%	+4.5%	+4.3%	+5.7%	+5.3%
Apr 10	Morgan Stanley	Downgrade	Equal Weight → Underweight	—	$78.93	$77.74	-1.5%	-1.8%	-1.8%	-3.8%	-2.9%	-4.9%
Nov 26	Cowen & Co.	Upgrade	Market Perform → Outperform	—	$73.65	$74.14	+0.7%	+1.1%	+1.0%	+2.0%	+3.4%	+4.0%
Nov 19	Goldman Sachs	Upgrade	Neutral → Conviction Buy	—	$73.42	$73.83	+0.6%	+0.6%	-0.9%	+1.5%	+0.3%	+1.4%
Sep 11	Citigroup	Upgrade	Neutral → Buy	—	$69.05	$70.20	+1.7%	+1.7%	+2.3%	+3.4%	+3.3%	+3.1%
Sep 10	BofA Securities	Upgrade	Underperform → Buy	—	$68.42	$69.12	+1.0%	+0.9%	+2.7%	+3.2%	+4.3%	+4.2%
Sep 10	Bank of America	Upgrade	Underperform → Buy	—	$68.42	$69.12	+1.0%	+0.9%	+2.7%	+3.2%	+4.3%	+4.2%
Jul 19	Barclays	Upgrade	Underweight → Equal Weight	—	$67.74	$67.79	+0.1%	-0.2%	+1.6%	+1.6%	+1.9%	+2.4%
May 29	HSBC	Downgrade	Buy → Hold	—	$63.67	$62.80	-1.4%	-1.5%	-0.5%	-2.1%	-0.7%	-0.5%
May 25	Credit Suisse	Upgrade	Underperform → Neutral	—	$63.73	$64.15	+0.7%	-0.1%	-1.6%	-0.6%	-2.2%	-0.8%
May 5	Argus	Upgrade	Hold → Buy	—	—	—	—	—	—	—	—	—
Jan 25	Leerink Swann	Maintains	Market Perform → Market Perform	—	$76.50	$77.88	+1.8%	+2.4%	+2.7%	+1.7%	+0.3%	-1.5%
Oct 25	Barclays	Downgrade	Equal Weight → Underweight	—	$69.55	$69.21	-0.5%	-2.1%	-2.7%	-2.9%	-1.7%	-0.7%
Oct 23	Leerink Swann	Maintains	Market Perform → Market Perform	—	$71.73	$72.14	+0.6%	+0.2%	-3.0%	-5.1%	-5.6%	-5.9%
Jul 26	Morgan Stanley	Upgrade	Underweight → Overweight	—	$70.45	$70.80	+0.5%	+0.8%	+0.9%	+0.7%	+1.2%	+1.3%
Jul 5	Credit Suisse	Downgrade	Neutral → Underperform	—	$69.94	$68.72	-1.7%	-0.6%	-1.9%	-1.5%	-1.8%	-1.9%
Apr 5	Cowen & Co.	Downgrade	Outperform → Market Perform	—	$62.56	$62.10	-0.7%	-1.3%	-1.4%	-1.4%	-1.7%	-1.1%
Jan 11	Credit Suisse	Downgrade	Outperform → Neutral	—	$62.00	$61.39	-1.0%	-1.9%	-1.8%	-2.3%	-2.9%	-3.0%
Jan 3	JP Morgan	Downgrade	Overweight → Neutral	—	$60.94	$60.98	+0.1%	-0.0%	-0.3%	+1.7%	+0.9%	+1.8%
Nov 10	Argus	Upgrade	Hold → Buy	—	$62.16	$61.73	-0.7%	-0.3%	-1.1%	-3.0%	-3.2%	-2.8%
Apr 12	Morgan Stanley	Downgrade	Equal Weight → Underperform	—	$62.84	$62.47	-0.6%	+0.1%	+0.5%	+1.3%	+0.7%	+1.6%
Apr 1	UBS	Downgrade	Buy → Neutral	—	$60.61	$58.49	-3.5%	-1.4%	+0.4%	+0.2%	+3.7%	+3.4%
Mar 29	Citigroup	Downgrade	Buy → Neutral	—	$61.18	$59.90	-2.1%	-1.0%	-0.8%	-0.9%	-2.4%	-0.5%
Mar 23	Leerink Swann	Downgrade	Outperform → Market Perform	—	$62.24	$62.63	+0.6%	-0.6%	-1.5%	-1.7%	-2.7%	-2.5%
Jul 27	Leerink Swann	Maintains	Outperform → Outperform	—	$85.17	$85.74	+0.7%	-0.3%	+1.0%	+1.9%	+1.4%	+1.9%
Jun 22	Bryan Garnier	Upgrade	Neutral → Buy	—	$83.82	$85.20	+1.6%	+1.9%	+2.6%	+1.4%	+0.6%	-0.3%
Mar 4	Natixis	Upgrade	Neutral → Buy	—	$82.88	$82.32	-0.7%	-0.0%	-0.1%	-1.6%	-1.1%	-2.9%
Jan 5	Cowen & Co.	Upgrade	Market Perform → Outperform	—	$77.18	$78.17	+1.3%	+0.2%	-0.6%	-0.2%	+3.3%	+4.2%